Pacylex Pharmaceuticals Announces New Executive Team Members as the Company Accelerates Clinical Development of PCLX-001

Pacylex is excited to welcome Michele Libonati and Annette Marcantonio to our team! We are happy to bring on Michele Libonati to the role of Chief Operating Officer (COO). In this new role, Ms. Libonati will oversee Pacylex’s day-to-day operations, including preclinical and clinical development, program management, and strategic and administrative functions. Ms. Libonati will report to Michael Weickert, Ph.D., Chief Executive Officer of Pacylex.

Joining Michele on the executive team is Annette Marcantonio who has been named Vice President of Clinical Operations, reporting to Ms. Libonati. Annette has more than 30 years of experience in senior clinical development and operations roles, leading large-scale clinical programs in complicated and novel therapeutic areas.

Find the full story here: Pacylex announces New Executive Team Members